Colgate-Palmolive Company (CL)
NYSE: CL · Real-Time Price · USD
89.95
-0.88 (-0.97%)
May 9, 2025, 3:50 PM - Market open
Colgate-Palmolive Company Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Colgate-Palmolive Company stock have an average target of 102.22, with a low estimate of 86 and a high estimate of 110. The average target predicts an increase of 13.64% from the current stock price of 89.95.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Colgate-Palmolive Company stock from 19 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 6 | 6 | 5 | 6 | 6 | 6 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 20 | 19 | 20 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $103 → $108 | Strong Buy | Maintains | $103 → $108 | +20.07% | Apr 28, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $95 → $103 | Buy | Maintains | $95 → $103 | +14.51% | Apr 28, 2025 |
| UBS | UBS | Strong Buy Maintains $105 → $109 | Strong Buy | Maintains | $105 → $109 | +21.18% | Apr 17, 2025 |
| Barclays | Barclays | Hold Maintains $89 → $86 | Hold | Maintains | $89 → $86 | -4.39% | Apr 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $99 → $95 | Buy | Maintains | $99 → $95 | +5.61% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
20.70B
from 20.10B
Increased by 2.98%
Revenue Next Year
21.55B
from 20.70B
Increased by 4.09%
EPS This Year
3.80
from 3.51
Increased by 8.22%
EPS Next Year
4.10
from 3.80
Increased by 7.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.4B | 22.3B | 23.2B | ||
| Avg | 20.7B | 21.5B | 22.4B | ||
| Low | 19.5B | 20.2B | 21.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.2% | 7.6% | 7.5% | ||
| Avg | 3.0% | 4.1% | 4.1% | ||
| Low | -3.2% | -2.5% | -2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.04 | 4.34 | 4.78 | ||
| Avg | 3.80 | 4.10 | 4.41 | ||
| Low | 3.48 | 3.77 | 4.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.2% | 14.2% | 16.6% | ||
| Avg | 8.2% | 7.9% | 7.7% | ||
| Low | -0.8% | -0.7% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.